logo BDSP

Base documentaire

  1. Good clinical practice and phytotherapy.

    Article - En anglais

    The GCP Guideline of the European Community on the performance of clinical trials became obligarory in June 1991.

    As the GCP standards have mainly been set for innovative drugs, there is a certain danger that these criteria could not be fulfilled by medicines used in phytotherapy.

    As regards, the chances and risks of the European guideline, especially for herbal medicines, the differences between chemically-defined and herbal drugs, as well as the extent, to which herbal medicines might be concerned by the guideline, have to be taken into account.

    Herbal medicines are different from chemically defined medicines in their character as well as in their medicinal use.

    They always contain a mixture of numerous substances.

    Mots-clés Pascal : Phytothérapie, Pharmacognosie, Traitement, Facteur risque, Législation, Recommandation, Plante médicinale, Extrait, Origine végétale, Essai clinique, Ethique, Allemagne, Europe

    Mots-clés Pascal anglais : Phytotherapy, Pharmacognosy, Treatment, Risk factor, Legislation, Recommendation, Medicinal plant, Extract, Plant origin, Clinical trial, Ethics, Germany, Europe

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 93-0478593

    Code Inist : 002B02A04. Création : 199406.